Results
Gufic Biosciences Q4 PAT Doubles to INR20.5 Crores
Gufic Biosciences reported Q4 FY26 revenue of INR252 crores, a 15% YoY increase, with PAT more than doubling to INR20.5 crores.
The Indore CMO facility reached 30% capacity utilization and EBITDA brea
